We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STNR
651
DELISTED
STEINER LEISURE LTD
STNR
| $1.46M | 0.01% |
30,767
| – | – |
|
|
FRP
652
DELISTED
Fairpoint Communications, Inc.
FRP
| $1.44M | 0.01% |
81,910
| – | – |
|
653
AAR Corp
AIR
$5.76B
| $1.43M | 0.01% |
46,673
-84,081
| -64% | -$2.49M |
|
654
Caleres
CAL
$487M
| $1.41M | 0.01% |
42,866
-95,060
| -69% | -$2.9M |
|
655
Clear Channel Outdoor Holdings
CCO
$1.23B
| $1.4M | 0.01% |
138,560
+19,469
| +16% | +$189K |
|
656
Zoetis
ZTS
$30B
| $1.39M | 0.01% |
+30,021
| New | +$1.35M |
|
657
Gentherm
THRM
$1.27B
| $1.38M | 0.01% |
27,301
+1,314
| +5% | +$55.6K |
|
|
TRIB
658
Trinity Biotech
TRIB
$8.39M
| $1.38M | 0.01% |
476
-530
| -53% | -$1.47M |
|
|
JRN
659
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $1.37M | 0.01% |
92,328
-14,226
| -13% | -$166K |
|
|
CIT
660
DELISTED
CIT Group Inc.
CIT
| $1.34M | 0.01% |
29,710
-36,125
| -55% | -$1.64M |
|
|
FRED
661
DELISTED
Fred's Inc
FRED
| $1.32M | 0.01% |
+77,507
| New | +$1.39M |
|
662
Manhattan Associates
MANH
$11.4B
| $1.32M | 0.01% |
+26,100
| New | +$1.26M |
|
663
Urban Edge Properties
UE
$2.73B
| $1.32M | 0.01% |
+55,536
| New | +$1.33M |
|
664
John B. Sanfilippo & Son
JBSS
$972M
| $1.31M | 0.01% |
+30,375
| New | +$1.18M |
|
665
Ambev
ABEV
$46.4B
| $1.31M | 0.01% |
+226,900
| New | +$1.41M |
|
|
CORE
666
DELISTED
Core Mark Holding Co., Inc.
CORE
| $1.3M | 0.01% |
40,580
-44,230
| -52% | -$1.45M |
|
667
iShares MSCI South Korea ETF
EWY
$25.7B
| $1.3M | 0.01% |
22,637
-456,525
| -95% | -$25.8M |
|
668
Eli Lilly
LLY
$1.06T
| $1.29M | 0.01% |
17,700
-378,843
| -96% | -$27M |
|
669
Regal Rexnord
RRX
$11.9B
| $1.28M | 0.01% |
16,049
-11,481
| -42% | -$860K |
|
670
Digi International
DGII
$3.1B
| $1.28M | 0.01% |
128,466
-9,463
| -7% | -$92.8K |
|
|
AAWW
671
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.28M | 0.01% |
29,777
+15,112
| +103% | +$705K |
|
|
ESND
672
DELISTED
Essendant Inc.
ESND
| $1.27M | 0.01% |
30,917
-40,485
| -57% | -$1.65M |
|
|
FINL
673
DELISTED
Finish Line
FINL
| $1.26M | 0.01% |
51,589
+40,352
| +359% | +$971K |
|
674
Walmart Inc
WMT
$890B
| $1.26M | 0.01% |
+45,900
| New | +$1.3M |
|
|
MN
675
DELISTED
MANNING & NAPIER, INC.
MN
| $1.26M | 0.01% |
96,618
| – | – |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.